Ignite Creation Date:
2024-05-06 @ 3:33 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04666766
Status:
RECRUITING
Last Update Posted:
2023-01-25
First Post:
2020-11-13
Brief Title:
Detecting Traumatic Intracranial Hemorrhage With Microwaves and Biomarkers
Sponsor:
Region Skane
Organization:
Region Skane
Study Overview
Official Title:
Detecting Traumatic Intracranial Hemorrhage With Microwaves and Biomarkers A Prospective Study Evaluating Ability of Microwave Scanning in Conjunction With Biomarkers to Diagnose Traumatic Intracranial Hemorrhage
Status:
RECRUITING
Status Verified Date:
2023-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MBI01
Brief Summary:
This study will evaluate if traumatic intracranial hemorrhage can be safely ruled out by using a microwave scanner MD100 in conjunction with a combination of different brain biomarkers analyzed in serum
Detailed Description:
This is a prospective open multicentre trial that will enrol patients presenting to the Emergency Department ED because of isolated head trauma or head trauma as part of a multi trauma Microwave scanning characteristics and biomarkers in patients with traumatic intracranial haemorrhage TICH Group A will be compared to patients with head trauma that do not have TICH Group B All adult patients with trauma to the head will be eligible for inclusion if a medical professional has evaluated the risk of spine injury After additional physical examination control of inclusion- and exclusion criteria and after informed consent has been acquired the microwave measurement and blood sampling will be performed Before enrolment in the study and in the acute phase one of the investigators or a member of the investigator staff must explain verbally the implications of study participation to the patient and the patient is asked to give a verbal consent As soon as is practically possible after the acute phase of the disease the patient will sign and personally date the informed consent form In cases where the patient is not capable to read andor sign the informed consent due to disability an independent witness shall be present throughout the process of reading the written informed consent and any other information aloud and explained to the prospective patient As an independent witness healthcare professionals who are not responsible or in any way involved in the patients care or treatment are accepted The independent witness can sign on the behalf of the patient in the presence of the patient and the Investigator More details of the informed consent procedure are described in this Clinical Investigation Plan section 63
The microwave measurement will take less than five minutes the duration of the actual measurement is about 15 min and will not interfere with the patients standard of care The Research Nurse or the Investigator documents all patient clinical trial information in the eCRF
Safety and usability will be evaluated throughout the trial and a safety follow-up will be performed by the Research Nurse or Investigator approximately 24 hours after the measurement procedure
During the data processing phase of study the result of the microwave measurement will be compared to the result of the biomarkers CT examination and the patients final diagnosis As a control group approximately 50 demographically matched healthy volunteers Group C will be asked to participate in the trial The trial will provide knowledge of the predictive value of microwave measurement and biomarkers for the diagnosis of intracranial haemorrhages in the acute TBI phase
The microwave measurement will take less than five minutes the duration of the actual measurement is about 15 min and will not interfere with the patients standard of care The Research Nurse or the Investigator documents all patient clinical trial information in the eCRF
Safety and usability will be evaluated throughout the trial and a safety follow-up will be performed by the Research Nurse or Investigator approximately 24 hours after the measurement procedure
During the data processing phase of study the result of the microwave measurement will be compared to the result of the biomarkers CT examination and the patients final diagnosis As a control group approximately 50 demographically matched healthy volunteers Group C will be asked to participate in the trial The trial will provide knowledge of the predictive value of microwave measurement and biomarkers for the diagnosis of intracranial haemorrhages in the acute TBI phase
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None